Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP973033.RAh-o9MFmEpXaJy1ZZxwd-ExkSogbNpWbWKRzDfQzBYcE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP973033.RAh-o9MFmEpXaJy1ZZxwd-ExkSogbNpWbWKRzDfQzBYcE130_assertion type Assertion NP973033.RAh-o9MFmEpXaJy1ZZxwd-ExkSogbNpWbWKRzDfQzBYcE130_head.
- NP973033.RAh-o9MFmEpXaJy1ZZxwd-ExkSogbNpWbWKRzDfQzBYcE130_assertion description "[As a strategy to define the embryonic origin and neurochemical phenotype of cells in this disease, we probed specimens (n = 10) resected during epilepsy surgery with a panel of 13 antibodies recognizing proteins associated with (i) specific progenitor cell types including brain lipid binding protein (BLBP), collapsin response mediator protein 4 (CRMP4), Dlx1, Dlx2, GFAPdelta, MASH1, Otx1, Pax6, vimentin and phosphorylated vimentin and (ii) excitatory or inhibitory neurochemical phenotypes such as the vesicular glutamate transporters-1 and 2 (VGLUT-1, VGLUT-2), or the vesicular GABA transporter (VGAT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973033.RAh-o9MFmEpXaJy1ZZxwd-ExkSogbNpWbWKRzDfQzBYcE130_provenance.
- NP973033.RAh-o9MFmEpXaJy1ZZxwd-ExkSogbNpWbWKRzDfQzBYcE130_assertion evidence source_evidence_literature NP973033.RAh-o9MFmEpXaJy1ZZxwd-ExkSogbNpWbWKRzDfQzBYcE130_provenance.
- NP973033.RAh-o9MFmEpXaJy1ZZxwd-ExkSogbNpWbWKRzDfQzBYcE130_assertion SIO_000772 17711980 NP973033.RAh-o9MFmEpXaJy1ZZxwd-ExkSogbNpWbWKRzDfQzBYcE130_provenance.
- NP973033.RAh-o9MFmEpXaJy1ZZxwd-ExkSogbNpWbWKRzDfQzBYcE130_assertion wasDerivedFrom befree-20150227 NP973033.RAh-o9MFmEpXaJy1ZZxwd-ExkSogbNpWbWKRzDfQzBYcE130_provenance.
- NP973033.RAh-o9MFmEpXaJy1ZZxwd-ExkSogbNpWbWKRzDfQzBYcE130_assertion wasGeneratedBy ECO_0000203 NP973033.RAh-o9MFmEpXaJy1ZZxwd-ExkSogbNpWbWKRzDfQzBYcE130_provenance.